Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03206177
Title Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Oklahoma
Indications

fallopian tube cancer

uterine cancer

ovarian cancer

carcinosarcoma

Therapies

Carboplatin + Galunisertib + Paclitaxel

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.